SCHEMBL24345983

SCHEMBL24345983

CC(=O)NC(C(=O)N[C@@H](C)C(=O)NCc1ccccc1)C(F)(F)F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.54
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA2 P00918 1/20 0.52
CA3 P07451 1/20 0.52
CA4 P22748 1/20 0.52
CA6 P23280 1/20 0.52
CA5A P35218 1/20 0.52
CA7 P43166 1/20 0.52
CACNA1C Q13936 1/20 0.52
SCN9A Q15858 1/20 0.52
CA9 Q16790 1/20 0.52
CA13 Q8N1Q1 1/20 0.52
CA14 Q9ULX7 1/20 0.52
CA5B Q9Y2D0 1/20 0.52
MME P08473 1/20 0.50
ALDH1A1 P00352 3/20 0.48
KMT2A Q03164 1/20 0.47
CYP3A4 P08684 1/20 0.46
MASP2 O00187 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24347010 0.85 MMP8 (0.63) MMP8CA12CA1CA2CA3
SCHEMBL993570 0.85 CA12 (0.64) MMP8CA12CA1CA2CA3
SCHEMBL6814514 0.85 CA12 (0.64) MMP8CA12CA1CA2CA3
SCHEMBL6813286 0.85 CA12 (0.64) MMP8CA12CA1CA2CA3
SCHEMBL24345984 0.84 BACE1 (0.55) MMP8KMT2A
SCHEMBL25214750 0.77 MMP8 (0.63) MMP8CA12CA1CA2CA3
SCHEMBL25240460 0.77 MMP8 (0.63) MMP8CA12CA1CA2CA3
SCHEMBL25214759 0.77 MMP8 (0.63) MMP8CA12CA1CA2CA3
SCHEMBL24347008 0.76 MMP8 (0.63) MMP8CA12CA1CA2CA3
SCHEMBL12436634 0.76 MMP8 (0.59) MMP8CA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119440-A1 PEPTIDE AND METHOD FOR MANUFACTURING SAME AGC Inc. (JP) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119440-A1 PEPTIDE AND METHOD FOR MANUFACTURING SAME VIP, RFC2, QRFPR MMP8 4499/4885CA12 588/4885CA1 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.